About this session
AllergoOncology, the interdisciplinary field at the intersection of allergy and oncology, explores the intricate relationship between allergies and cancer. This emerging area of research investigates how immune responses generally associated with allergies may impact cancer development. By examining the immunological mechanisms underlying both allergic reactions and anti-tumor responses, AllergoOncology aims to uncover potential therapeutic targets and prognostic indicators in cancer patients. For example, it has been shown that immunoglobulin E, the key molecule in allergic reactions, has a role in anti-tumor surveillance. On the other hand, patients with very low total serum IgE levels are at an increased risk to develop cancer. Therefore, understanding the complex interplay between allergic inflammation and tumor microenvironments may lead to novel strategies for cancer prevention and immunotherapy.
AllergoOncology, the interdisciplinary field at the intersection of allergy and oncology, explores the intricate relationship between allergies and cancer. This emerging area of research investigates how immune responses generally associated with allergies may impact cancer development. By examining the immunological mechanisms underlying both allergic reactions and anti-tumor responses, AllergoOncology aims to uncover potential therapeutic targets and prognostic indicators in cancer patients. For example, it has been shown that immunoglobulin E, the key molecule in allergic reactions, has a role in anti-tumor surveillance. On the other hand, patients with very low total serum IgE levels are at an increased risk to develop cancer. Therefore, understanding the complex interplay between allergic inflammation and tumor microenvironments may lead to novel strategies for cancer prevention and immunotherapy.